Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Xtant Medical Holdings (XTNT) over the last 16 years, with Q3 2025 value amounting to $150.4 million.

  • Xtant Medical Holdings' Shares Outstanding (Diluted Average) rose 1130.79% to $150.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.4 million, marking a year-over-year increase of 1130.79%. This contributed to the annual value of $133.7 million for FY2024, which is 541.97% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Shares Outstanding (Diluted Average) stood at $150.4 million for Q3 2025, which was up 1130.79% from $148.6 million recorded in Q2 2025.
  • Xtant Medical Holdings' Shares Outstanding (Diluted Average)'s 5-year high stood at $150.4 million during Q3 2025, with a 5-year trough of $81.2 million in Q1 2021.
  • Over the past 5 years, Xtant Medical Holdings' median Shares Outstanding (Diluted Average) value was $108.9 million (recorded in 2023), while the average stood at $113.4 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 55571.62% in 2021, then tumbled by 41.5% in 2024.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Shares Outstanding (Diluted Average) stood at $85.5 million in 2021, then grew by 10.1% to $94.1 million in 2022, then soared by 34.76% to $126.8 million in 2023, then rose by 5.42% to $133.7 million in 2024, then increased by 12.5% to $150.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $150.4 million in Q3 2025, compared to $148.6 million in Q2 2025 and $143.3 million in Q1 2025.